9 Week Eczema (Atopic Dermatitis) Study

The purpose of this study is to assess the safety and effectiveness of an investigational medication cream compared to placebo (inactive substance) in the treatment of mild-to-moderate eczema.

People who have had a diagnosis of atopic dermatitis for at least 6 months and are aged 18 and older may qualify to receive study drug at no cost.  There is no cost to participate, and participants will receive compensation for travel related expenses.

In order to qualify, participants must have 1%-15% of their body surface area covered in eczema, excluding their palms, soles, and scalp.  This is equivalent to 1-15 palm sized patches, including fingers.

Participants will be asked to visit the study centre about 7 times over a period of about 9 weeks.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more